All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
ConclusionAll-oral DEVEC showed an encouraging activity and acceptable toxicity. This schedule deserves further studies in elderly PTCL also for assessing combinations with targeted drugs.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Italy Health | Leukemia | Lymphoma | Oral Cancer | Prednisolone | Study | T-cell Lymphoma | Toxicology